REVISTA DE EDUCATIE MEDICALA CONTINUA DEDICATA GINECOLOGILOR,
OBSTETRICENILOR, MOASELOR SI ASISTENTILOR MEDICALI DIN ROMANIA

<- Home <- Arhive <- Anul 8, Nr. 30, December 2020



RevistaGinecologia8(30)46-49(2020)
© VERSA PULS MEDIA, S.R.L.


Cervical cancer screening

G.M. Voinea, M.I. Bratu, V. Nimigean, F. Isopescu


Rezumat: Cervical cancer remains an important public health issue even after the discovery of Papanicolaou screening test (1940) that facilitated the early detection of the illness. Identifying the human papillomavirus (HPV) as a leading cause, alongside with developments in molecular HPV screening and HVP vaccines, resulted in an important decrease in cervical cancer mortality rates. For developing the best screening method, there are still ongoing studies which assess the performance of existing methods and implementation of vaccines. The early detection of uterine cancer in the body is solely based on screening programs that require HPV testing.
Cuvinte cheie: human papillomavirus, cervical cytology, cervical cancer, HPV testing.

Full Text in PDF
© 2008-2024 revistaginecologia.ro. All rights reserved
created by if else factory